Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
European Journal of Preventive Cardiology|March 27, 2021
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Cristian Topriceanu, Chen Qu, et al.
Journal of the American College of Cardiology|May 19, 2022
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic CardiomyopathyGabrielle Norrish, Aoife Cleary, Ella Field, et al.
JAMA Cardiology|May 12, 2021
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart FailureMohammed Majid Akhtar, Massimiliano Lorenzini, Menelaos Pavlou, et al.
European Heart Journal|July 15, 2021
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathyLuis R Lopes, Soledad Garcia-Hernández, Massimiliano Lorenzini, et al.
Circulation. Arrhythmia and Electrophysiology|May 2, 2022
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic CardiomyopathyGabrielle Norrish, Tao Ding, Ella Field, et al.
European Heart Journal|September 17, 2024
Clinical features and outcomes in carriers of pathogenic desmoplakin variantsAlessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
European Heart Journal|June 27, 2013
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)Michele Brignole, Angelo Auricchio, Gonzalo Baron-Esquivias, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Journal of the American College of Cardiology|November 17, 2018
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic CardiomyopathyJuan Pablo Ochoa, María Sabater-Molina, José Manuel García-Pinilla, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
European Journal of Preventive Cardiology|March 27, 2021
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathyGabrielle Norrish, Cristian Topriceanu, Chen Qu, et al.
Journal of the American College of Cardiology|May 19, 2022
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic CardiomyopathyGabrielle Norrish, Aoife Cleary, Ella Field, et al.
JAMA Cardiology|May 12, 2021
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart FailureMohammed Majid Akhtar, Massimiliano Lorenzini, Menelaos Pavlou, et al.
European Heart Journal|July 15, 2021
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathyLuis R Lopes, Soledad Garcia-Hernández, Massimiliano Lorenzini, et al.
Circulation. Arrhythmia and Electrophysiology|May 2, 2022
Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic CardiomyopathyGabrielle Norrish, Tao Ding, Ella Field, et al.
European Heart Journal|September 17, 2024
Clinical features and outcomes in carriers of pathogenic desmoplakin variantsAlessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
European Heart Journal|June 27, 2013
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)Michele Brignole, Angelo Auricchio, Gonzalo Baron-Esquivias, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Journal of the American College of Cardiology|November 17, 2018
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic CardiomyopathyJuan Pablo Ochoa, María Sabater-Molina, José Manuel García-Pinilla, et al.
Pageof 30